These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 28325710)

  • 41. Take -home naloxone rescue kits following heroin overdose in the emergency department to prevent opioid overdose related repeat emergency department visits, hospitalization and death- a pilot study.
    Papp J; Vallabhaneni M; Morales A; Schrock JW
    BMC Health Serv Res; 2019 Dec; 19(1):957. PubMed ID: 31829228
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Naloxone distribution and possession following a large-scale naloxone programme.
    Madah-Amiri D; Gjersing L; Clausen T
    Addiction; 2019 Jan; 114(1):92-100. PubMed ID: 30129078
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The relationship between naloxone dose and key patient variables in the treatment of non-fatal heroin overdose in the prehospital setting.
    Cantwell K; Dietze P; Flander L
    Resuscitation; 2005 Jun; 65(3):315-9. PubMed ID: 15919568
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Patient perspectives on an opioid overdose education and naloxone distribution program in the U.S. Department of Veterans Affairs.
    Oliva EM; Nevedal A; Lewis ET; McCaa MD; Cochran MF; Konicki PE; Davis CS; Wilder C
    Subst Abus; 2016; 37(1):118-26. PubMed ID: 26675643
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Factors Associated With Participation in an Emergency Department-Based Take-Home Naloxone Program for At-Risk Opioid Users.
    Kestler A; Buxton J; Meckling G; Giesler A; Lee M; Fuller K; Quian H; Marks D; Scheuermeyer F
    Ann Emerg Med; 2017 Mar; 69(3):340-346. PubMed ID: 27745764
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Retrospective Review of Need for Delayed Naloxone or Oxygen in Emergency Department Patients Receiving Naloxone for Heroin Reversal.
    Heaton JD; Bhandari B; Faryar KA; Huecker MR
    J Emerg Med; 2019 Jun; 56(6):642-651. PubMed ID: 30961922
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Acceptability of prison-based take-home naloxone programmes among a cohort of incarcerated men with a history of regular injecting drug use.
    Curtis M; Dietze P; Aitken C; Kirwan A; Kinner SA; Butler T; Stoové M
    Harm Reduct J; 2018 Sep; 15(1):48. PubMed ID: 30241532
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Predictors of participant engagement and naloxone utilization in a community-based naloxone distribution program.
    Rowe C; Santos GM; Vittinghoff E; Wheeler E; Davidson P; Coffin PO
    Addiction; 2015 Aug; 110(8):1301-10. PubMed ID: 25917125
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Summaries for patients: naloxone for heroin overdose reversal.
    Ann Intern Med; 2013 Jan; 158(1):I-30. PubMed ID: 23277911
    [No Abstract]   [Full Text] [Related]  

  • 50. Brief overdose education can significantly increase accurate recognition of opioid overdose among heroin users.
    Jones JD; Roux P; Stancliff S; Matthews W; Comer SD
    Int J Drug Policy; 2014 Jan; 25(1):166-70. PubMed ID: 23773683
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ethical issues and stakeholders matter.
    Dale O
    Addiction; 2016 Apr; 111(4):587-9. PubMed ID: 26995170
    [No Abstract]   [Full Text] [Related]  

  • 52. Heroin overdose resuscitation with naloxone: patient uses own prescribed supply to save the life of a peer.
    Winston I; McDonald R; Tas B; Strang J
    BMJ Case Rep; 2015 Sep; 2015():. PubMed ID: 26370638
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Overdose training and take-home naloxone for opiate users: prospective cohort study of impact on knowledge and attitudes and subsequent management of overdoses.
    Strang J; Manning V; Mayet S; Best D; Titherington E; Santana L; Offor E; Semmler C
    Addiction; 2008 Oct; 103(10):1648-57. PubMed ID: 18821875
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Patterns of polysubstance use and overdose among people who inject drugs in Baltimore, Maryland: A latent class analysis.
    Schneider KE; Park JN; Allen ST; Weir BW; Sherman SG
    Drug Alcohol Depend; 2019 Aug; 201():71-77. PubMed ID: 31195347
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Attitudes of Australian heroin users to peer distribution of naloxone for heroin overdose: perspectives on intranasal administration.
    Kerr D; Dietze P; Kelly AM; Jolley D
    J Urban Health; 2008 May; 85(3):352-60. PubMed ID: 18347990
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Emergency naloxone for heroin overdose: naloxone is not the only opioid antagonist.
    Brewer C
    BMJ; 2006 Oct; 333(7571):754-5. PubMed ID: 17023477
    [No Abstract]   [Full Text] [Related]  

  • 57. Evaluation of overdose prevention trainings in New York City: Knowledge and self-efficacy among participants 12 months after training.
    Maldjian L; Siegler A; Kunins HV
    Subst Abus; 2016; 37(3):459-465. PubMed ID: 26731134
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of a naloxone distribution and administration program in New York City.
    Piper TM; Stancliff S; Rudenstine S; Sherman S; Nandi V; Clear A; Galea S
    Subst Use Misuse; 2008; 43(7):858-70. PubMed ID: 18570021
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Heroin: life, death, and politics.
    Jacobson J
    Am J Nurs; 2014 May; 114(5):22-3. PubMed ID: 24759473
    [No Abstract]   [Full Text] [Related]  

  • 60. Homeless drug users' awareness and risk perception of peer "take home naloxone" use--a qualitative study.
    Wright N; Oldham N; Francis K; Jones L
    Subst Abuse Treat Prev Policy; 2006 Oct; 1():28. PubMed ID: 17014725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.